Pimavanserin
1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
Molecular Identity
Pimavanserin
1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
PubChem CID: 10071196
Pimavanserin is a member of the class of ureas in which three of the four hydrogens are replaced by 4-fluorobenzyl, 1-methylpiperidin-4-yl, and 4-(isopropyloxy)benzyl groups. An atypical antipsychotic that is used (in the form of its tartrate salt) for treatment of hallucinations and delusions associated with Parkinson's disease. It has a role as a 5-hydroxytryptamine 2A receptor inverse agonist, an antipsychotic agent and a serotonergic antagonist. It is a member of piperidines, an aromatic ether, a member of ureas, a tertiary amino compound and a member of monofluorobenzenes. It is a conjugate base of a pimavanserin(1+).
2D Structure
Properties
C25H34FN3O2
Molecular Formula
427.60
Molecular Weight
g/mol
427.2635
Exact Mass
Da
4.5
XLogP
Drug-like (Lipinski: < 5)
44.8
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
4
H-Bond Acceptors
523
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Pimavanserin706779-91-1ACP-103pimavanserinapimavanserineJZ963P0DIKCHEBI:133017DTXSID90990906N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamideACP 103N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-{[4-(2-methylpropoxy)phenyl]methyl}ureapimavanserinum1-((4-fluorophenyl)methyl)-1-(1-methylpiperidin-4-yl)-3-((4-(2-methylpropoxy)phenyl)methyl)urea
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Pimavanserin
Loading drug network...